CNSP News and Press, CNS Pharmaceuticals Inc. From 12/23/21

The Food and Drug Administration recently released new guidance informing sponsors of clinical trials on recommendations to trial designs for systemic oncologic treatments in individuals with central nervous system metastases . According to the new guidelines, researchers must consider le...

Two new studies led by researchers from Yale have discovered new information about the ALK receptor (anaplastic lymphoma kinase molecule) and the role it plays in cancer formation. The studies have made progress in determining ALK’s structure status as a receptor protein. Their find...

A new study has found that the rate of survival for young individuals diagnosed with central nervous system (“CNS”) tumors is higher the farther they live from healthcare facilities. Associate professor at the Brown School at Washington University Kimberly Johnson reported &#...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received approval from the Switzerland Ethics Committee (swissethics) — the first appro...

CNS Pharmaceuticals (NASDAQ:CNSP) has received approval from swissethics, the umbrella organization of the cantonal Ethics Committees (EC) in Switzerland, for its potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), a type of brain cancer. Share...

CNS Pharmaceuticals Receives Approval from Switzerland Ethics Committee for its Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM) Approval is the first from a European Ethics Committee for the potentially pivotal study of Berubicin with ad...

New research has found that white British individuals who have been diagnosed with a malignant brain tumor have a higher risk of mortality than those from other ethnicities. The research’s findings were presented at the NCRI Festival. The study assessed the influence of an individ...

Progenity PROG +20% amid social media buzz Canoo (NASDAQ:GOEV) +17%. Camber Energy (NYSE:CEI) +17%. Asia Pacific Wire & Cable APWC +14% on 1H results SPI Energy (NASDAQ:SPI) +13%. Ensysce Biosciences (NASDAQ:ENSC) +11%. Mullen Automotive (NASDAQ:MULN) +10%. Vir Biotechnolog...

Gainers: BIMI International Medical (NASDAQ:BIMI) +55%. Kezar Life Sciences (NASDAQ:KZR) +31%. CNS Pharmaceuticals (NASDAQ:CNSP) +28%. ReTo Eco-Solutions (NASDAQ:RETO) +28%. Progenity (NASDAQ:PROG) +27%. PLBY Group (NASDAQ:PLBY) +27%. IonQ (NYSE:IONQ) +25%. Kuke (NYSE:KUKE) +21%. On Holding (...

CNS Pharmaceuticals to Present at the Virtual Investor Roundtable Event Live moderated video webcast discussion among members of management on Thursday, November 18th at 9:00 AM ET PR Newswire HOUSTON , Nov. 16, 2021 /PRNewswire/ -- CNS Pharmaceuticals, I...